WO2003043610A3 - A process for manufacture of a sustained release composition containing microbe - Google Patents

A process for manufacture of a sustained release composition containing microbe Download PDF

Info

Publication number
WO2003043610A3
WO2003043610A3 PCT/IN2002/000223 IN0200223W WO03043610A3 WO 2003043610 A3 WO2003043610 A3 WO 2003043610A3 IN 0200223 W IN0200223 W IN 0200223W WO 03043610 A3 WO03043610 A3 WO 03043610A3
Authority
WO
WIPO (PCT)
Prior art keywords
manufacture
composition containing
sustained release
release composition
containing microbe
Prior art date
Application number
PCT/IN2002/000223
Other languages
French (fr)
Other versions
WO2003043610A2 (en
Inventor
Amit Krishna Antarkar
Rajendra Ghanshamlal Lala
Gaurang Hasmukhlal Thanawala
Maya Janak Shah
Janak Ramanlal Shah
Original Assignee
Themis Lab Private Ltd
Amit Krishna Antarkar
Rajendra Ghanshamlal Lala
Gaurang Hasmukhlal Thanawala
Maya Janak Shah
Janak Ramanlal Shah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Themis Lab Private Ltd, Amit Krishna Antarkar, Rajendra Ghanshamlal Lala, Gaurang Hasmukhlal Thanawala, Maya Janak Shah, Janak Ramanlal Shah filed Critical Themis Lab Private Ltd
Priority to EP02803493A priority Critical patent/EP1448173A2/en
Priority to AU2002356425A priority patent/AU2002356425A1/en
Priority to HU0500382A priority patent/HUP0500382A3/en
Publication of WO2003043610A2 publication Critical patent/WO2003043610A2/en
Publication of WO2003043610A3 publication Critical patent/WO2003043610A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel compositions and process for manufacturing of novel pharmaceutical compositions in the form of microbeads comprising of trimetazidine dihydrochloride and further coating of the beads with polymeric membrane to tailor the drug release characteristics enabling 'once a day' dosing for 60 mg dose of trimetazidine dihydrochloride per unit dose.
PCT/IN2002/000223 2001-11-21 2002-11-20 A process for manufacture of a sustained release composition containing microbe WO2003043610A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02803493A EP1448173A2 (en) 2001-11-21 2002-11-20 A process for manufacture of a sustained release pharmaceutical composition containing microbeads of trimetazidine dihydrochloride
AU2002356425A AU2002356425A1 (en) 2001-11-21 2002-11-20 A process for manufacture of a sustained release composition containing microbe
HU0500382A HUP0500382A3 (en) 2001-11-21 2002-11-20 Sustained release pharmaceutical compositions containing microbeads of trimetazidine dihydrochloride and process for producing them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1106MU2001 2001-11-21
IN1106/MUM/2001 2001-11-21

Publications (2)

Publication Number Publication Date
WO2003043610A2 WO2003043610A2 (en) 2003-05-30
WO2003043610A3 true WO2003043610A3 (en) 2003-08-21

Family

ID=11097321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2002/000223 WO2003043610A2 (en) 2001-11-21 2002-11-20 A process for manufacture of a sustained release composition containing microbe

Country Status (4)

Country Link
EP (1) EP1448173A2 (en)
AU (1) AU2002356425A1 (en)
HU (1) HUP0500382A3 (en)
WO (1) WO2003043610A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885807B1 (en) * 2005-05-18 2008-05-16 Mg Pharma SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
WO2009034541A2 (en) 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
TR201001902A2 (en) 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Trimetazidine tablets with extended release
US20110274751A1 (en) 2010-05-04 2011-11-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Trimetazidine formulation with different release profiles
CN102133195A (en) * 2011-03-17 2011-07-27 王国栋 Trimetazidine dihydrochloride sustained control release pellet and preparation method thereof
FR2986431B1 (en) * 2012-02-03 2017-03-17 Servier Lab PROLONGED RELEASE OF TRIMETAZIDINE PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PRODUCTION THEREOF AND USE IN THERAPEUTIC TREATMENTS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0673649A1 (en) * 1994-03-24 1995-09-27 Adir Et Compagnie Pharmaceutical compositions for the prolonged release of trimetazidine after oral administration

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0673649A1 (en) * 1994-03-24 1995-09-27 Adir Et Compagnie Pharmaceutical compositions for the prolonged release of trimetazidine after oral administration

Also Published As

Publication number Publication date
EP1448173A2 (en) 2004-08-25
WO2003043610A2 (en) 2003-05-30
AU2002356425A1 (en) 2003-06-10
HUP0500382A2 (en) 2005-07-28
HUP0500382A3 (en) 2008-03-28
AU2002356425A8 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
HUP0302086A2 (en) Oral pharmaceutical composition with a delayed action and process for its preparation
CA2253980A1 (en) Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
ATE396712T1 (en) PHARMACEUTICAL PREPARATION FOR MODIFIED RELEASE
IL220888A0 (en) 3,10 and 12 a substituted tetracyline compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
GB0003154D0 (en) Novel compounds
WO2007052125A3 (en) Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
IL167038A (en) Pyrazole derivatives, pharmaceutical compositions containing the same, use thereof in the manufacture of medicaments and intermediate for production thereof
WO2004012699A3 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
WO2005048979A3 (en) Pharmaceutical composition having casing with multiple micro tablets
CA2375946A1 (en) Pharmaceutical tablet and process for making thereof
WO2004108162A3 (en) Controlled release pharmaceutical composition
IL204947A0 (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them
CY1107576T1 (en) EXTREMELY RELEASE OF WATER SOLUBLE MEDICINAL SUBSTANCES
HK1067626A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
AU2003215245A1 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
CA2489407A1 (en) Lasofoxifene tablet and its coating
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
ATE442852T1 (en) DELAYED-RELEASE MEDICINAL COMPRISING TRIMETAZIDINE AND METHOD FOR THE PRODUCTION
EP1238662A3 (en) Method for manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules
WO2006041843A3 (en) Pharmaceutical dosage form comprising meloxicam
WO2003043610A3 (en) A process for manufacture of a sustained release composition containing microbe
WO2003082262A3 (en) Compositions of venlafaxine base
MY134340A (en) Pharmaceutical formulation having a masked taste and method for the production thereof
WO2003048298A3 (en) Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002803493

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002803493

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP